BURLINGTON, Mass., Feb. 12 /PRNewswire-FirstCall/ --
Palomar Medical Technologies Inc (Nasdaq: PMTI) today announced that the
super-fast, low-cost Palomar EsteLux(TM) Light-Based System is officially
better than ever, having recently been cleared by the FDA for pigmented lesion
treatments. Last year, the system had already been cleared for hair removal.
Palomar believes that the EsteLux, which was originally designed to provide
customers with good quality at an affordable price, is now without question
one of the most value-priced devices on the market.
(Photo: http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO )
Briana Heniford, M.D. of the Charlotte Center for Aesthetics & Cutaneous
Oncology, P.C. commented "I originally purchased the Palomar EsteLux for its
hair removal application. To my surprise, the pigmented lesion business has
equaled the hair removal business. The pigmented lesions treated are primarily
Solar Lentigo, better known as age-spots or sunspots. My patients are
extremely happy with the treatment results on both the face and hands. They
find the procedure comfortable and quick, even on large body areas such as
chest, back, arms and legs."
Chairman and CEO, Dan Valente, said "As a hair removal system alone, the
Palomar EsteLux has generated intense interest. With our recent FDA clearance
for pigmented lesions and our clinical success in this area, I am more excited
than ever about the product. The EsteLux has proven to work great on age-spots
and sunspots and other common skin discolorations. For a relatively low price,
a treatment provider can buy a safe and effective, high-quality system that
actually does hair removal and pigmented lesion treatments. What's more, the
system is inexpensive to operate, given its extremely long 100,000-pulse lamp
life. It's truly a superb device as well as an intelligent investment."
The Palomar EsteLux light-based system combines the latest flashlamp
technology with simple, streamlined engineering and is both effective and
economical. The system features a high pulse rate and a large spot size that
makes the system extremely effective when treating large areas such as legs
and backs. Users can treat more customers in less time, maximizing their
return on investment. The system is smaller and lighter than current systems,
which is especially desirable for mobile and/or small physician offices. The
systems simple operation opens its applications to a wider band of worldwide
users to include; Dermatologists, General Practice Physicians, Cosmetic or
Aesthetic Physicians, Doctor Supervised Spas and Aesthetic Salons just to name
a few.
About Palomar Medical Technologies Inc: Palomar is the leading researcher
and developer of proprietary laser/light based systems for hair removal and
other cosmetic treatments and is the first company to obtain clearance from
the FDA for "permanent hair reduction." Palomar hair removal systems have been
installed in practices worldwide, and hundreds of thousands of treatments have
been performed. New and exciting indications are being tested to further
advance the hair removal market and other cosmetic applications including fat
reduction, acne treatment and skin rejuvenation.
To get more information regarding Palomar and its products, please visit
Palomar's web site at http://www.palmed.com. Also, to continue to receive the most
up-to-date information and latest news on Palomar as it happens, sign up to
receive automatic e-mail alerts by going to the e-mail alerts page in the
Investor Relations' section of the web site.
With the exception of the historical information contained in this
release, the matters described herein contain forward-looking statements,
including but not limited to statements relating to new markets, development
and introduction of new products, and financial projections that involve risk
and uncertainties that may individually or mutually impact the matters herein,
and cause actual results, events and performance to differ materially from
such forward-looking statements. These risk factors include, but are not
limited to, results of future operations, technological difficulties in
developing or introducing new products, the results of future research, lack
of product demand and market acceptance for current and future products, the
effect of economic conditions, the impact of competitive products and pricing,
governmental regulations with respect to medical devices, including whether
FDA clearance will be obtained for future products, the results of litigation,
potential infringement of third-party intellectual property rights, and/or
other factors, which are detailed from time to time in the company's SEC
reports, including the report on Form 10-K for the year ended December 31,
2000 and the Company's quarterly reports on Form 10-Q. Readers are cautioned
not to place undue reliance on these forward-looking statements, which speak
only as of the date hereof. The company undertakes no obligation to release
publicly the result of any revisions to these forward-looking statements that
may be made to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
Contact:
Paul S. Weiner,
Treasurer
781-993-2411 or ir@palmed.com
SOURCE Palomar Medical Technologies Inc
 back to top
Related links:
http://www.palmed.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/107555.html
CONTACT:
Paul S. Weiner, Treasurer of Palomar Medical
Technologies Inc., +1-781-993-2411, ir@palmed.com
|
